Please assess the completion status of the following clinical trial:

Trial Title: The Role of the Coagulation Pathways in Recurrent Angioedema

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* recurrent angioderma~Exclusion Criteria:~* anticoagulant therapy, diseases of hemostasis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Arm 1 AE-Bk (Type: OTHER): Arm of the recurring angiodeme medié by the bradykinine: blood test
- Arm 2 AE-Mast (Type: OTHER): Superficial nettle rash group recurring angiodemes associated with superficial nettle rash: blood test
- ARM 3 AEI (Type: OTHER): Arm recurring angiodemes isolate idiopathique not hostaminergique: blood test
- ARM 4 US (Type: OTHER): Arm of superficial nettle rashes: blood test

Based on this trial design, predict the completion outcome and termination type (if applicable).